Latest News from Pro PG

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Dear Healthcare Professional, Shortage of OZEMPIC 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen The

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Dear Healthcare Professional, Shortage of AUGMENTIN DUO FORTE tablet blister pack 875mg/125mg (Amoxicillin Trihydrate and Pot

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Dear Healthcare Professional, Shortage of AUGMENTIN DUO FORTE tablet blister pack 875mg/125mg (Amoxicillin Trihydrate and Pot

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has received the Section 19A extension to supply of Imipramine 25mg Tablets until 28th February 202

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered BENPEN benzylpenicillin (as sodium)

CheckMed, our newly formed company, is dedicated to leveraging artificial intelligence (AI) to predict shortages of vaccines, medical devices, and drugs. We firmly believe that AI holds the key to analysing data and making well-informed decisions. Prediction is only half the solution — see how ProPG supports bridging supply gaps during shortages. Please see the CheckMed website for more details www.checkmed.ai CheckMed's predictive signals also feed directly into our new sho

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 10mg Tablets until 15th October 2021

Pro PG team filled in June 2020 a large order for critical ICU medicine needed by our Europe based client in their region. This represents the 3rd large shipment we have completed in the COVID-19 period into 3 different regions. Projects were sucessfully managed by the Pro PG team.

Pro PG team filled a large order for critical ICU medicine needed by our client in their region. This was a considerable large shipment totalling 13 pallets of stock. This represented our 2nd large shipment in the COVID period the same ICU medicine. The Project was successfully managed by Lukasz Nowaczek our Poland based representative who worked closely with our dedicated logistic partner in this challenging COVID-19 period.

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. ​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.